Mucin-5AC pre-mRNA (MUC5AC (pre-mRNA))

MUC5AC pre-mRNA" refers to the unprocessed, nascent transcript of the human mucin-5AC gene (MUC5AC), which contains both exons and introns. This precursor RNA undergoes splicing to form the mature MUC5AC mRNA, which is then translated into the heavily glycosylated gel-forming mucin-5AC protein. The MUC5AC protein is a key protective component of mucus in gastric, respiratory, and other epithelial tissues[1][3][8]. While MUC5AC protein is an established biomarker and possible therapeutic target in diseases such as cancer, respiratory disease, and gastrointestinal disorders, the pre-mRNA itself does not have a direct therapeutic or pathological role. Referring to "MUC5AC pre-mRNA" as a drug target is likely incorrect—the term usually reflects molecular or genetic studies, not direct pharmacological targeting[1][2][3][8]. Explanation for curation: - The mature Mucin-5AC protein is well-established as both diagnostic/prognostic biomarker and therapeutic target in cancer, respiratory, and gastrointestinal diseases[1][2][3][8]. - The pre-mRNA is not a canonical drug target, receptor, or enzyme. It does not appear as a direct therapeutic target in the literature, though its splicing or processing may be manipulated experimentally in basic research. - No drugs directly interact with MUC5AC pre-mRNA in clinical practice; instead, agents may regulate the gene's transcription or the protein's function. - Therefore, this query appears to be incorrect or at least highly unusual for clinical or translational contexts. - The correct canonical target to capture is Mucin-5AC protein (gene: MUC5AC), not the pre-mRNA.

Other names

MUC5AC mRNAMUC5AC transcriptMUC5AC precursor RNA